AFJK — Aimei Health Technology Co Income Statement
0.000.00%
- $67.52m
- $67.72m
- 25
- 53
- 48
- 37
Annual income statement for Aimei Health Technology Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
---|---|---|
Period Length: | 12 M | 12 M |
Source: | 10-K | 10-K |
Standards: | USG | USG |
Status: | Final | Final |
Total Revenue | 0 | 0 |
Other Operating Expenses | ||
Total Operating Expenses | 0.028 | 1.06 |
Operating Profit | -0.028 | -1.06 |
Total Net Non Operating Interest Income / Expense | ||
Net Income Before Taxes | 0.171 | 2.55 |
Net Income After Taxes | 0.171 | 2.55 |
Net Income Before Extraordinary Items | ||
Net Income | 0.171 | 2.55 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||
Income Available to Common Shareholders Including Extraordinary Items | ||
Diluted Net Income | 0.171 | 2.55 |
Diluted Weighted Average Shares | ||
Basic EPS Including Extraordinary Items | ||
Diluted EPS Including Extraordinary Items | ||
Diluted EPS Excluding Extraordinary Items | ||
Normalised Income Before Taxes | ||
Normalised Income After Taxes | ||
Normalised Income Available to Common Shareholders | ||
Diluted Normalised EPS | 0.019 | 0.283 |